公开(公告)号：US20240114932A1

公开(公告)日：2024-04-11

申请号：US18544847

申请日：2023-12-19

申请人： PURECIRCLE SDN BHD ,  THE COCA-COLA COMPANY

发明人： Avetik MARKOSYAN ,  Indra PRAKASH

IPC分类号： A23L2/60 ,  A01H4/00 ,  A01H5/12 ,  A01H6/14 ,  A21D2/18 ,  A21D2/36 ,  A21D13/062 ,  A23C9/13 ,  A23G3/36 ,  A23G4/06 ,  A23L2/52 ,  A23L2/54 ,  A23L27/30 ,  A23L33/105 ,  A61K8/9789 ,  A61Q1/00 ,  A61Q11/00 ,  C07H1/08 ,  C07H15/24 ,  C07H15/256 ,  C12N15/82

CPC分类号： A23L2/60 ,  A01H4/005 ,  A01H4/008 ,  A01H5/12 ,  A01H6/1488 ,  A21D2/181 ,  A21D2/36 ,  A21D13/062 ,  A23C9/1307 ,  A23G3/36 ,  A23G4/06 ,  A23L2/52 ,  A23L2/54 ,  A23L27/36 ,  A23L33/105 ,  A61K8/9789 ,  A61Q1/00 ,  A61Q11/00 ,  C07H1/08 ,  C07H15/24 ,  C07H15/256 ,  C12N15/8282 ,  A61K36/00

摘要： A Stevia extract made from leaves of the Stevia rebaudiana plant is described. The extract has desired levels of steviol glycosides and is useful in food, beverage, and other consumable products.

公开(公告)号：US11938184B2

公开(公告)日：2024-03-26

申请号：US17203687

申请日：2021-03-16

申请人： Gaurav Agrawal

发明人： Gaurav Agrawal

IPC分类号： A61K39/395 ,  A23C9/123 ,  A23G3/36 ,  A23G4/06 ,  A23G4/12 ,  A23G9/32 ,  A23G9/36 ,  A61K31/133 ,  A61K31/4164 ,  A61K31/435 ,  A61K31/496 ,  A61K31/498 ,  A61K31/7048 ,  A61K33/00 ,  A61K39/00 ,  A61K39/40

CPC分类号： A61K39/39533 ,  A23C9/123 ,  A23G3/36 ,  A23G3/364 ,  A23G4/06 ,  A23G4/12 ,  A23G9/32 ,  A23G9/36 ,  A61K31/133 ,  A61K31/4164 ,  A61K31/435 ,  A61K31/496 ,  A61K31/498 ,  A61K31/7048 ,  A61K33/00 ,  A61K39/3955 ,  A61K39/40 ,  A61K2039/505 ,  Y02A50/30

摘要： In alternative embodiments, the invention provides a “triple combination” therapy for treating, ameliorating and preventing Crohn's Disease (or Crohn syndrome, terminal or distal ileitis or regional enteritis) or related disorders and conditions in mammals, such as paratuberculosis in mammals, or Johne's disease, including genetically-predisposed and chronic disorders, where the microbial or bacterial flora of the bowel is at least one causative or symptom-producing factor; and compositions for practicing same. In alternative embodiments, methods and compositions of the invention comprise or comprise use of therapies, medications, formulations and pharmaceuticals comprising active agents that can suppress or eradicate the microbiota super-infection that causes Crohn's Disease or paratuberculosis infection in mammals. In alternative embodiments, the methods and uses of the invention for treating, ameliorating and preventing Crohn's Disease and complications of Crohn's Disease, or related disorders and conditions in mammals, such as paratuberculosis in mammals, or Johne's disease, comprises administration to an individual (human or mammal) in need thereof: (1) an anti-TNFα composition, or a composition capable of down-modulating TNFα activity; (2) a Hyperbaric Oxygen Treatment, or HBOT; and (3) an anti Mycobacterium avium sub species paratuberculosis (MAP) (an anti-MAP) agent, composition or therapy.

公开(公告)号：US20230374052A1

公开(公告)日：2023-11-23

申请号：US18365370

申请日：2023-08-04

申请人： PURECIRCLE USA INC.

发明人： Avetik MARKOSYAN ,  Siew Yin CHOW ,  Khairul NIZAM BIN NAWI

IPC分类号： C07H1/08 ,  C07H1/06 ,  A61Q11/00 ,  A61K8/60 ,  A23L27/30 ,  A23G1/40 ,  A23L2/60 ,  B01D15/18 ,  A21D2/18 ,  A23C9/13 ,  A23G3/42 ,  A23G9/34 ,  A23L2/02 ,  A61K36/28 ,  A61K31/704 ,  A61K31/7034 ,  B01D15/08 ,  C07H15/256 ,  A23G1/32 ,  A23G3/36 ,  A23G4/06 ,  A23G4/10 ,  A23G9/32 ,  A23C19/09 ,  A23C9/156

CPC分类号： C07H1/08 ,  C07H1/06 ,  A61Q11/00 ,  A61K8/602 ,  A23L27/36 ,  A23G1/40 ,  A23L2/60 ,  B01D15/1871 ,  A21D2/181 ,  A23C9/1307 ,  A23G3/42 ,  A23G9/34 ,  A23L2/02 ,  A61K36/28 ,  A61K31/704 ,  A61K31/7034 ,  B01D15/08 ,  C07H15/256 ,  A23G1/32 ,  A23G3/36 ,  A23G4/06 ,  A23G4/10 ,  A23G9/32 ,  A23C19/0925 ,  A23C9/156 ,  A23L27/50

摘要： Methods of preparing steviol glycosides, including Rebaudioside D, Rebaudioside E, Rebaudioside M, Rebaudioside N and Rebaudioside O are provided herein. Sweetener and sweetened consumables containing Rebaudioside D, Rebaudioside E, Rebaudioside M, Rebaudioside N and Rebaudioside O are also provided herein.

公开(公告)号：US20180319745A1

公开(公告)日：2018-11-08

申请号：US15768031

申请日：2016-10-19

申请人： FIRMENICH SA

发明人： Michael J. CALANDRA ,  Ying WANG ,  John IMPELLIZZERI

IPC分类号： C07C409/20 ,  C11D3/50 ,  C11B9/00 ,  A23L27/20 ,  A23L2/56 ,  A23L2/39 ,  A23G3/36

CPC分类号： C07C409/20 ,  A23G3/36 ,  A23L2/39 ,  A23L2/56 ,  A23L27/2026 ,  A23L27/2028 ,  A23L27/203 ,  A23V2002/00 ,  C07C2601/16 ,  C11B9/0015 ,  C11B9/0034 ,  C11D3/507

摘要： Provided herein is a compound of Formula I: wherein R represents a terpene hydroperoxyl selected from the group consisting of wherein R′ represents a alkyl group selected from the group consisting: CH3(CH2)8—, CH3(CH2)6—, and CH3—.

公开(公告)号：US10081826B2

公开(公告)日：2018-09-25

申请号：US15366209

申请日：2016-12-01

申请人： Conagen Inc.

发明人： Guohong Mao ,  Xiaodan Yu

IPC分类号： C12P19/56 ,  C12P19/18 ,  C12N9/10 ,  C12N9/90 ,  C12N15/11 ,  A23G3/38 ,  A23G3/36 ,  A23G4/06 ,  A23L27/30 ,  C12N15/52 ,  A23L33/105 ,  A21D13/062 ,  A23L2/60 ,  C07H15/24

CPC分类号： C12P19/56 ,  A21D13/062 ,  A23G3/36 ,  A23G3/38 ,  A23G4/06 ,  A23L2/60 ,  A23L27/33 ,  A23L27/36 ,  A23L33/105 ,  A23V2002/00 ,  C07H15/24 ,  C12N9/1048 ,  C12N9/1051 ,  C12N9/1062 ,  C12N15/52 ,  C12Y204/00 ,  C12Y204/01

摘要： Recombinant polypeptides having UDP-glycosyltransferase activities, including a 1,2-19-O-glucose glycosylation activity and a 1,2-13-O-glucose glycosylation activity for synthesizing of steviol glucosides, are provided. A method of producing a steviol glycoside composition using such recombinant polypeptide is also provided. Also disclosed are steviol glycosides referred to as rebaudioside Z1 and rebaudioside Z2.

公开(公告)号：US20180132517A1

公开(公告)日：2018-05-17

申请号：US15872646

申请日：2018-01-16

申请人： Sensient Colors LLC

发明人： Michael Charles Jelavich ,  Gale Denise Myers ,  Andreas Klingenberg

IPC分类号： A23L29/212 ,  A23G3/42 ,  A23L5/41 ,  A23G3/36

CPC分类号： A23L29/212 ,  A23G3/36 ,  A23G3/42 ,  A23L5/41 ,  A23V2002/00

摘要： An opacity modifying agent in particulate form comprising a starch, a dextrin, an optional film former, and an optional binder is disclosed herein. Also provided is an opacity modifying suspension comprising the opacity modifying agent and a liquid. The opacity modifying agent or suspension can be added to edible products to provide increased opacity. Methods of producing the opacity modifying agent are also disclosed.

公开(公告)号：US09814748B2

公开(公告)日：2017-11-14

申请号：US13856060

申请日：2013-04-03

申请人： Takasago International Corp. (USA)

发明人： Charles Manley ,  David J. Spence ,  Carter B. Green

IPC分类号： A61K36/28 ,  A61K36/61 ,  A23G3/34 ,  A23G3/36 ,  A23G3/48 ,  A23G4/06 ,  A23L2/02 ,  A23L2/56 ,  A61K31/16 ,  A61K31/194 ,  A61K36/81 ,  A61K36/9068 ,  A61K45/06 ,  A23L27/00 ,  A23L27/14 ,  A23L27/20 ,  A23L33/105

CPC分类号： A61K36/61 ,  A23G3/34 ,  A23G3/36 ,  A23G3/48 ,  A23G4/06 ,  A23G4/068 ,  A23L2/02 ,  A23L2/56 ,  A23L27/14 ,  A23L27/20 ,  A23L27/82 ,  A23L33/105 ,  A23V2002/00 ,  A61K31/16 ,  A61K31/194 ,  A61K36/28 ,  A61K36/81 ,  A61K36/9068 ,  A61K45/06 ,  A61K2300/00 ,  A23V2200/15 ,  A23V2250/032 ,  A23V2250/606 ,  A23V2250/21

摘要： Provides is a salivation cocktail that comprises a food acid and a tingling sensate. The combination of a food acid and a tingling sensate has been found to synergistically increase salivation.

公开(公告)号：US20170274071A1

公开(公告)日：2017-09-28

申请号：US15483702

申请日：2017-04-10

申请人： CENTRE FOR DIGESTIVE DISEASES

发明人： Gaurav AGRAWAL

IPC分类号： A61K39/395 ,  A23C9/123

CPC分类号： A61K39/39533 ,  A23C9/123 ,  A23G3/36 ,  A23G4/06 ,  A23G9/32 ,  A61K31/133 ,  A61K31/4164 ,  A61K31/435 ,  A61K31/496 ,  A61K31/498 ,  A61K31/7048 ,  A61K33/00 ,  A61K39/3955 ,  A61K39/40 ,  A61K2039/505 ,  Y02A50/474 ,  A61K39/00

摘要： In alternative embodiments, the invention provides a “triple combination” therapy for treating, ameliorating and preventing Crohn's Disease (or Crohn syndrome, terminal or distal ileitis or regional enteritis) or related disorders and conditions in mammals, such as paratuberculosis in mammals, or Johne's disease, including genetically-predisposed and chronic disorders, where the microbial or bacterial flora of the bowel is at least one causative or symptom-producing factor; and compositions for practicing same. In alternative embodiments, methods and compositions of the invention comprise or comprise use of therapies, medications, formulations and pharmaceuticals comprising active agents that can suppress or eradicate the microbiota super-infection that causes Crohn's Disease or paratuberculosis infection in mammals. In alternative embodiments, the methods and uses of the invention for treating, ameliorating and preventing Crohn's Disease and complications of Crohn's Disease, or related disorders and conditions in mammals, such as paratuberculosis in mammals, or Johne's disease, comprises administration to an individual (human or mammal) in need thereof: (1) an anti-TNFα composition, or a composition capable of down-modulating TNFα activity; (2) a Hyperbaric Oxygen Treatment, or HBOT; and (3) an anti-Mycobacterium avium sub species paratuberculosis (MAP) (an anti-MAP) agent, composition or therapy.

公开(公告)号：US20170245520A1

公开(公告)日：2017-08-31

申请号：US15511562

申请日：2015-09-16

申请人： WM. WRIGLEY JR. COMPANY

发明人： Sonya S. Johnson ,  Gloria T. Sheldon ,  Shanna Sticka ,  Lisa Tran ,  Darci Chidichimo ,  Donna Oh

IPC分类号： A23G4/06 ,  A24B15/34 ,  A23P10/30 ,  A23G3/36 ,  A23G4/08

CPC分类号： A23G4/06 ,  A23G3/36 ,  A23G4/08 ,  A23L27/12 ,  A23L27/72 ,  A23P10/30 ,  A24B15/00 ,  A24B15/16 ,  A24B15/34 ,  A61K36/534

摘要： Consumer products containing cultivar mint oil selected from the group consisting of ginger mint, blue balsam tea mint, macho mint, julep mint, banana mint, sweet pear mint, lavender mint, spearmint, peppermint and combinations thereof for a new sensory-organoleptic experience. Consumer products include chewing gum, confection, lozenge, edible film, pastilles, dentifrice, toothpaste, mouthwash, mouth spray, tobacco, pharmaceuticals, and edible films.

公开(公告)号：US20170239233A1

公开(公告)日：2017-08-24

申请号：US15411205

申请日：2017-01-20

申请人： Fertin Pharma A/S

发明人： HELLE WITTORFF ,  KIRSTEN LUND

IPC分类号： A61K31/465 ,  A61K9/20 ,  A61K9/68

CPC分类号： A61K9/0056 ,  A23G3/36 ,  A23G3/42 ,  A23G4/08 ,  A23G4/10 ,  A23G4/18 ,  A23G4/20 ,  A23L33/10 ,  A23V2002/00 ,  A24B13/00 ,  A24B15/10 ,  A61K9/0058 ,  A61K9/2027 ,  A61K31/465

摘要： The invention relates to a chewable tablet including a polymer system, tobacco powder, flavor and sweetener, at least about 70% by weight of the polymer system being polyvinyl acetate (PVAc) and less than 10% by weight of the polymer system being polymer having a molecular weight (Mw) of greater than about 50000 g/mol.